The landing of the Chinese Academy of Sciences medical heavy ion accelerator project in Shenzhen medical equipment "aircraft carrier" will benefit the people of the Bay Area

The domestically produced medical heavy ion accelerator appeared at the annual meeting of the International Particle Radiotherapy Cooperation Organization.

[Hong Kong Business Daily Online News] Reporter Chang Liang reported that the reporter learned yesterday that recently, Shenzhen Overseas Chinese Town Cultural Real Estate Investment Co., Ltd., Shenzhen Daotian Medical Technology Co., Ltd. and Guoke Ion Medical Technology Co., Ltd. signed a tripartite cooperation agreement, intending to give full play to the tripartite advantages and introduce the medical heavy ion accelerator project developed by the Institute of Modern Physics of the Chinese Academy of Sciences, Build the first "Heavy Ion Tumor Treatment Center" in Shenzhen's Greater Bay Area, and conduct in-depth cooperation in the promotion and application of domestic high-end medical equipment to achieve win-win development.

The reporter learned that this tripartite cooperation is based on thorough research in the early stage, and after multiple communication and negotiation, a consensus was reached. The three parties signed a formal cooperation agreement at the end of May 2019, intending to build the first heavy ion tumor treatment center in Dawan District, Shenzhen Guangming District, Loucun Health Industrial Park. Tong Haitao, Executive Director of Shenzhen Daotian Medical Technology Co., Ltd., introduced that this cooperation marks the arrival of the largest independently developed medical equipment in China in the Greater Bay Area, which will greatly improve the medical and health level of the Greater Bay Area, provide international professional medical services for the development and construction of the Greater Bay Area, and drive the development of related industries.

OCT Group Co., Ltd. is a large state-owned enterprise directly managed by the State owned Assets Supervision and Administration Commission of the State Council. As a wholly-owned subsidiary of OCT Group Co., Ltd., Shenzhen OCT Cultural Real Estate Investment Co., Ltd. has undertaken the implementation of the innovative development model of "culture+tourism+urbanization" and "tourism+Internet plus+finance" of the group in recent years, and is responsible for promoting the planning, land Investment and construction, as well as management and operation work.

Guoke Ion Co., Ltd. is a company initiated by Chinese Academy of Sciences Holding Co., Ltd. and the Institute of Modern Physics of Chinese Academy of Sciences to promote the industrialization of scientific and technological achievements in heavy ion cancer treatment. Guoke Ions plans to utilize its platform and technological advantages, committed to the integration of advanced medical technology with finance and services, providing integrated solutions and services for ion diagnosis, treatment, health and wellness, and conducting sales and promotion of heavy ion treatment equipment, financial support, operation and maintenance, consulting services, personnel training, ion medical big data services, and cutting-edge new technology research to serve the construction of a healthy China.

According to statistics, more than 4 million cancer patients are added every year in China, and the incidence rate is rising year by year. Radiation therapy has become one of the fastest-growing sub industries in the field of medical devices and related services, and heavy ion therapy is currently internationally recognized as the most advanced radiation therapy technology. Currently, only a few developed countries such as Germany, Japan, and the United States possess this technology internationally.

Heavy ion beam has unique physical and biological characteristics, and heavy ion therapy is known as the most advanced, accurate, efficient, and safe radiation therapy method at present. It has minimal damage to healthy tissues, minimal side effects, short treatment period, and high cure rate, making it particularly suitable for the treatment of difficult to treat tumors such as those that are not suitable for surgery and are not sensitive to conventional radiation, "Cai Xiaohong, a member of the National Committee of the Chinese People's Political Consultative Conference and Chairman of Guoke Ionic Medical Technology Co., Ltd., told reporters, This cooperation reflects the strong alliance between heavy ion cancer treatment technology and industry and capital, and also marks the landing of major technology industry application projects of the Chinese Academy of Sciences in the Greater Bay Area. She pointed out that compared to conventional radiotherapy, heavy ions can accurately and efficiently kill tumors without affecting normal tissues, with almost no side effects, and patients have no pain. At present, the Institute of Modern Physics of the Chinese Academy of Sciences has cooperated with the hospital to complete the preclinical trial research of 213 tumor patients, and has achieved remarkable curative effects. It has become the first institution in China and the fourth in the world to master the clinical treatment technology of heavy ions, has trained a high-level team of heavy ion treatment technicians, and has broken through and mastered the relevant key technologies, We have developed the first compact heavy ion therapy system with independent intellectual property rights in China, which is superior to imported equipment in terms of technology, performance, price, and operation and maintenance guarantee. The Wuwei heavy ion therapy demonstration device has completed registration and testing, and clinical treatment and follow-up observation of 46 subjects have been completed. The clinical results meet the registration requirements for Class III medical devices.

With the advancement of artificial intelligence technology, artificial intelligence can also be used for tumor diagnosis, treatment plan formulation, automatic positioning, and positioning verification, which can reduce waiting time for treatment, improve treatment efficiency, and improve treatment effectiveness. "Tong Haitao told reporters that in recent years, the Greater Bay Area has gathered multiple high-level and comprehensive medical and research platforms represented by Sun Yat sen University Cancer Hospital, with strong talent teams and research capabilities, The construction of a heavy ion therapy tumor project in the Greater Bay Area and the implementation and transformation of advanced domestic heavy ion therapy technologies are important practices for the transformation of major scientific and technological achievements of the Chinese Academy of Sciences, and also a concrete manifestation of seizing the development opportunities of the Guangdong Hong Kong Macao Greater Bay Area.

More noteworthy is the establishment of the Future Greater Bay Area Heavy Ion Tumor Treatment Center, which will carry out research on heavy ion therapy for characteristic local diseases such as nasopharyngeal inflammation, improve the treatment and medical research level of difficult to treat tumors, benefit patients in South China, Hong Kong, Macao, and Southeast Asia, and create an international first-class heavy ion precision medical research and clinical medicine research center, a comprehensive research platform for tumor treatment precision radiotherapy, and a heavy ion cloud hospital The precision radiotherapy medical talent training platform and ion medical health base will play a demonstration and leading role, and will become a landmark "business card" of the Greater Bay Area.